| Field | Specification |
|---|---|
| Target | |
| Alternative names | Apoptosis regulator BAX;Bcl-2-like protein 4;Bcl2-L-4;BAX;BCL2L4; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the N-terminus of human Bax, different from the related mouse and rat sequences by five amino acids. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody detects apoptosis regulator BAX in human, mouse and rat samples and is validated for flow cytometry, ICC/IF, IHC and Western blot. The predicted molecular weight is 21.2 kDa, and the supplier reports an observed band at about 21 kDa.
BAX is a pro-apoptotic effector of the Bcl-2 family that is mostly cytosolic in healthy cells. Apoptotic signals cause BAX to insert into the mitochondrial outer membrane and oligomerize, permeabilizing it and releasing cytochrome c to activate caspases. BAX and BAK together are the gatekeepers of intrinsic apoptosis.
| Target | Apoptosis regulator BAX (gene BAX; UniProt Q07812, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4 |
| Calculated MW | 21.2 kDa |
| Observed MW | 21 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.1–0.5 µg/mL (Human, Rat) |
|---|---|
| IHC (paraffin sections) | 2–5 µg/mL (Human, Mouse, Rat) |
| Immunocytochemistry / Immunofluorescence | 5 µg/mL (Human) |
| Flow cytometry (fixed cells) | 1–3 µg/1×106 cells (Human) |
Samples with a confirmed band (WB): human THP-1 cells, human MCF-7 cells, human A549 cells, human HeLa cells, human HeLa- WT cells, human Hela-BAX KO cells, rat C6 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 12% SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human lung cancer tissue, mouse kidney tissue, rat kidney tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Samples with confirmed staining (ICC/IF): A549 cells.
Samples with confirmed staining (ICC/IF): mouse uterus tissue.
Samples with a confirmed signal (flow cytometry): THP-1 cells.
Immunogen
Synthetic peptide from the N-terminal region of human bax. It differs from the mouse and rat sequences at five residues.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. Tissue expression noted by UniProt (human): Expressed in a wide variety of tissues. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Tianxin Zhao et al. (2021) Prenatal exposure to environmentally relevant levels of PBDE-99 leads to testicular dysgenesis with steroidogenesis disorders. Journal of Hazardous Materials. 10.1016/j.jhazmat.2021.127547
Liangliang Dai et al. (2020) Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy. Biomaterials. 10.1016/j.biomaterials.2020.119901
Su Li et al. (2025) GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer. Materials Today Bio. 10.1016/j.mtbio.2025.102030
Zhu Xiao-Ren et al. (2025) A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer. Cell Death & Disease. 10.1038/s41419-025-07410-9
Liangliang Dai et al. (2017) Dual-Targeted Cascade-Responsive Prodrug Micelle System for Tumor Therapy in Vivo. Chemistry of Materials. 10.1021/acs.chemmater.7b02513
Shuiqin Niu et al. (2017) Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model. Theranostics. 10.7150/thno.16562
Liu Lu et al. (2022) SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling. Journal of Translational Medicine. 10.1186/s12967-022-03500-w
Liangliang Dai et al. (2016) Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo. Biomaterials. 10.1016/j.biomaterials.2016.07.002
Ling-Kun Zhang et al. (2019) Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment. Chemical Engineering Journal. 10.1016/j.cej.2019.03.216
Lu Kong et al. (2021) Mechanisms underlying reproductive toxicity induced by nickel nanoparticles identified by comprehensive gene expression analysis in GC-1 spg cells. Environmental Pollution. 10.1016/j.envpol.2021.116556
